Bioregenx (BRGX) Return on Equity (2022 - 2026)

Bioregenx's Return on Equity history runs 5 years deep, the most recent figure standing at 0.0% for Q1 2026.

• In Q1 2026, Return on Equity fell 6.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (down 6.0% YoY), while the FY2025 annual figure was 0.0%, down 8.0% from the prior year.
• Return on Equity was 0.0% for Q1 2026 at Bioregenx, down from 0.0% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.06% in Q1 2025 to a low of 0.04% in Q4 2024.
• Historically, Return on Equity has averaged 0.01% across 5 years, with a median of 0.0% in 2023.
• The sharpest annual moves came in 2025 and 2026: Return on Equity rose 6 bps in 2025, then declined 6 bps in 2026.
• A 5-year view of Return on Equity shows it stood at 0.0% in 2022, then soared by 584 bps to 0.0% in 2023, then sank by 1129 bps to 0.04% in 2024, then jumped by 109 bps to 0.0% in 2025, then decreased by 18 bps to 0.0% in 2026.
• The last three Return on Equity figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.05% (Q3 2025), per Business Quant data.